Ghosal hematodiaphyseal dysplasia: A rare cause of a myelophthisic anemia

Parisa Mazaheri, Girish Nadkarni, Elizabeth Lowe, Patrick Hines, Melena Vuica, Matthew Griffin, Linda M Smith Resar

Research output: Contribution to journalArticle

Abstract

Ghosal hematodiaphyseal dysplasia syndrome (GHDD) is a rare clinical syndrome characterized by increased bone density and a severe, myelophthisic anemia. Few cases have been reported worldwide and there are no detailed descriptions of the associated hematologic abnormalities and long-term clinical outcomes after treatment. Here, we report two siblings with GHDD who were successfully treated with chronic, low dose, corticosteroid therapy. Although GHDD is uncommon, these cases illustrate the need to consider GHDD in patients with anemia and bone dysplasia and the use of chronic, low-dose steroid therapy.

Original languageEnglish (US)
Pages (from-to)1187-1190
Number of pages4
JournalPediatric Blood and Cancer
Volume55
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Myelophthisic Anemia
Developmental Bone Disease
Bone Density
Anemia
Siblings
Adrenal Cortex Hormones
Steroids
Ghosal Hematodiaphyseal Dysplasia
Therapeutics

Keywords

  • Anemia
  • Diaphyseal dysplasia
  • Ghosal syndrome

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Ghosal hematodiaphyseal dysplasia : A rare cause of a myelophthisic anemia. / Mazaheri, Parisa; Nadkarni, Girish; Lowe, Elizabeth; Hines, Patrick; Vuica, Melena; Griffin, Matthew; Smith Resar, Linda M.

In: Pediatric Blood and Cancer, Vol. 55, No. 6, 12.2010, p. 1187-1190.

Research output: Contribution to journalArticle

Mazaheri, P, Nadkarni, G, Lowe, E, Hines, P, Vuica, M, Griffin, M & Smith Resar, LM 2010, 'Ghosal hematodiaphyseal dysplasia: A rare cause of a myelophthisic anemia' Pediatric Blood and Cancer, vol. 55, no. 6, pp. 1187-1190. https://doi.org/10.1002/pbc.22662
Mazaheri P, Nadkarni G, Lowe E, Hines P, Vuica M, Griffin M et al. Ghosal hematodiaphyseal dysplasia: A rare cause of a myelophthisic anemia. Pediatric Blood and Cancer. 2010 Dec;55(6):1187-1190. https://doi.org/10.1002/pbc.22662
Mazaheri, Parisa ; Nadkarni, Girish ; Lowe, Elizabeth ; Hines, Patrick ; Vuica, Melena ; Griffin, Matthew ; Smith Resar, Linda M. / Ghosal hematodiaphyseal dysplasia : A rare cause of a myelophthisic anemia. In: Pediatric Blood and Cancer. 2010 ; Vol. 55, No. 6. pp. 1187-1190.
@article{b90f4757655d4869b5ef1636d4185482,
title = "Ghosal hematodiaphyseal dysplasia: A rare cause of a myelophthisic anemia",
abstract = "Ghosal hematodiaphyseal dysplasia syndrome (GHDD) is a rare clinical syndrome characterized by increased bone density and a severe, myelophthisic anemia. Few cases have been reported worldwide and there are no detailed descriptions of the associated hematologic abnormalities and long-term clinical outcomes after treatment. Here, we report two siblings with GHDD who were successfully treated with chronic, low dose, corticosteroid therapy. Although GHDD is uncommon, these cases illustrate the need to consider GHDD in patients with anemia and bone dysplasia and the use of chronic, low-dose steroid therapy.",
keywords = "Anemia, Diaphyseal dysplasia, Ghosal syndrome",
author = "Parisa Mazaheri and Girish Nadkarni and Elizabeth Lowe and Patrick Hines and Melena Vuica and Matthew Griffin and {Smith Resar}, {Linda M}",
year = "2010",
month = "12",
doi = "10.1002/pbc.22662",
language = "English (US)",
volume = "55",
pages = "1187--1190",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Ghosal hematodiaphyseal dysplasia

T2 - A rare cause of a myelophthisic anemia

AU - Mazaheri, Parisa

AU - Nadkarni, Girish

AU - Lowe, Elizabeth

AU - Hines, Patrick

AU - Vuica, Melena

AU - Griffin, Matthew

AU - Smith Resar, Linda M

PY - 2010/12

Y1 - 2010/12

N2 - Ghosal hematodiaphyseal dysplasia syndrome (GHDD) is a rare clinical syndrome characterized by increased bone density and a severe, myelophthisic anemia. Few cases have been reported worldwide and there are no detailed descriptions of the associated hematologic abnormalities and long-term clinical outcomes after treatment. Here, we report two siblings with GHDD who were successfully treated with chronic, low dose, corticosteroid therapy. Although GHDD is uncommon, these cases illustrate the need to consider GHDD in patients with anemia and bone dysplasia and the use of chronic, low-dose steroid therapy.

AB - Ghosal hematodiaphyseal dysplasia syndrome (GHDD) is a rare clinical syndrome characterized by increased bone density and a severe, myelophthisic anemia. Few cases have been reported worldwide and there are no detailed descriptions of the associated hematologic abnormalities and long-term clinical outcomes after treatment. Here, we report two siblings with GHDD who were successfully treated with chronic, low dose, corticosteroid therapy. Although GHDD is uncommon, these cases illustrate the need to consider GHDD in patients with anemia and bone dysplasia and the use of chronic, low-dose steroid therapy.

KW - Anemia

KW - Diaphyseal dysplasia

KW - Ghosal syndrome

UR - http://www.scopus.com/inward/record.url?scp=77958543657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958543657&partnerID=8YFLogxK

U2 - 10.1002/pbc.22662

DO - 10.1002/pbc.22662

M3 - Article

VL - 55

SP - 1187

EP - 1190

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -